BNP Paribas Financial Markets’s Neon Therapeutics, Inc. Common Stock NTGN Stock Holding History

BNP Paribas Financial Markets’s Portfolio NTGN Stock Details NTGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-4,425	Closed	-$11.7K	–	4452
2020 Q1	$11.7K	Buy	4,425 +986	+29%	+$1.62K	﹤0.01%	4007
2019 Q4	$4.06K	Buy	3,439 +1,095	+47%	+$1.75K	﹤0.01%	4197
2019 Q3	$4.03K	Buy	2,344 +42	+2%	+$128	﹤0.01%	4297
2019 Q2	$10.9K	Sell	2,302 -922	-29%	-$5.16K	﹤0.01%	4086
2019 Q1	$20.8K	Buy	3,224 +3,206	+17,811%	+$16.8K	﹤0.01%	3898
2018 Q4	$91	Buy	+18	New	+$126	﹤0.01%	4195

BNP Paribas Financial Markets's NTGN Position: Q2 2020 in Review

BNP Paribas Financial Markets sold out of Neon Therapeutics, Inc. Common Stock (NTGN) in Q2 2020, closing a stake of 4,425 shares — an estimated $11.7K sold.

BNP Paribas Financial Markets first reported a position in NTGN in Q4 2018 and held it in 6 quarters. The position peaked at $20.8K in Q1 2019. 0 funds tracked by Wall St. Rank hold NTGN as of Q2 2020.

BNP Paribas Financial Markets reported no remaining Neon Therapeutics, Inc. Common Stock position as of Q2 2020 after selling out during the quarter.
BNP Paribas Financial Markets sold 4,425 Neon Therapeutics, Inc. Common Stock shares in Q2 2020, an estimated $11.7K.
BNP Paribas Financial Markets first reported a position in Neon Therapeutics, Inc. Common Stock in Q4 2018 and held it in 6 quarters.
BNP Paribas Financial Markets's Neon Therapeutics, Inc. Common Stock position peaked at $20.8K in Q1 2019.
0 funds tracked by Wall St. Rank held Neon Therapeutics, Inc. Common Stock as of Q2 2020.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2020, filed 6 Aug 2020.